About NASH Summit
Focused on discovery through to late stage clinical development of non-alcoholic steatohepatitis candidate pipelines, the 2nd Annual NASH Summit will bring together 150+ drug developers from 120+ organizations in the most comprehensive forum of the NASH calendar.
The 2nd Annual NASH Summit will provide you with the data, insight and lessons learned that will enable you to:
- Understand how to progress your candidate towards a combinational NASH treatment and more effectively address this huge unmet medical need
- Define clinical primary and secondary endpoints and understand the status of the biopsy at the time current NASH candidates will enter market to map out your clinical trials
- Utilize metabolomic and inflammatory biomarkers in NASH preclinical development models to more robustly diagnose and track NASH disease progression
- Improve drug efficacy in both early and late stage NASH by identifying and validating novel targets & drug mechanisms of action
Join your peers in Boston to overcome the challenges that are preventing you from accelerating the development of your NASH candidate.
Download the full event guide for the complete agenda and speaker line-up.